Bristol Myers Squibb (BMY)
(Delayed Data from NYSE)
$50.94 USD
+0.93 (1.86%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $50.94 0.00 (0.00%) 7:16 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
- YR Estimate
- 12/31/2023
- 12/31/2022
- 12/31/2021
- 12/31/2020
- 12/31/2019
- Revenue - Line of Business (LOBR)
- Revenues: Net product sales
- 43,778.00
- 44,671.00
- 45,055.00
- 41,321.00
- 25,174.00
- Revenue - Line of Business (LOBR)
- Revenues: Alliance and other revenue
- 1,228.00
- 1,488.00
- 1,330.00
- 1,197.00
- 971.00
- Revenue - Line of Business (LOBR)
- Net Sales: In-Line Products: Eliquis
- 12,206.00
- 11,789.00
- 10,762.00
- 9,168.00
- 7,929.00
- Revenue - Line of Business (LOBR)
- Net Sales: In-Line Products: Opdivo
- 9,009.00
- 8,249.00
- 7,523.00
- 6,992.00
- 7,204.00
- Revenue - Line of Business (LOBR)
- Net Sales: In-Line Products: Pomalyst/Imnovid
- 3,441.00
- 3,497.00
- 3,332.00
- 3,070.00
- 322.00
- Revenue - Line of Business (LOBR)
- Net Sales: In-Line Products: Orencia
- 3,601.00
- 3,464.00
- 3,306.00
- 3,157.00
- 2,977.00
- Revenue - Line of Business (LOBR)
- Net Sales: In-Line Products: Sprycel
- 1,930.00
- 2,165.00
- 2,117.00
- 2,140.00
- 2,110.00
- Revenue - Line of Business (LOBR)
- Net Sales: In-Line Products: Yervoy
- 2,238.00
- 2,131.00
- 2,026.00
- 1,682.00
- 1,489.00
- Revenue - Line of Business (LOBR)
- Net Sales: New Product Portfolio: Opdualag
- 627.00
- 252.00
- 0.00
- --
- --
- Revenue - Line of Business (LOBR)
- Net Sales: New Product Portfolio: Abecma
- 472.00
- 388.00
- 164.00
- 0.00
- --
- Revenue - Line of Business (LOBR)
- Net Sales: New Product Portfolio: Zeposia
- 434.00
- 250.00
- 134.00
- 12.00
- --
- Revenue - Line of Business (LOBR)
- Net Sales: New Product Portfolio: Reblozyl
- 1,008.00
- 717.00
- 551.00
- 274.00
- --
- Revenue - Line of Business (LOBR)
- Net Sales: Recent LOE Products: Abraxane
- 1,004.00
- 811.00
- 1,181.00
- 1,247.00
- 166.00
- Revenue - Line of Business (LOBR)
- Net Sales: Recent LOE Products: Revlimid
- 6,097.00
- 9,978.00
- 12,821.00
- 12,106.00
- 1,299.00
- Revenue - Line of Business (LOBR)
- Net Sales: New Product Portfolio: Breyanzi
- 364.00
- 182.00
- 87.00
- 0.00
- --
- Revenue - Line of Business (LOBR)
- Net Sales: New Product Portfolio: Sotyktu
- 170.00
- 8.00
- 0.00
- --
- --
- Revenue - Line of Business (LOBR)
- Net Sales: New Product Portfolio: Camzyos
- 231.00
- 24.00
- 0.00
- --
- --
- Revenue - Geographic (GEOR)
- Total Revenues: U.S.
- 31,555.00
- 31,828.00
- 29,214.00
- 26,577.00
- 15,342.00
- Revenue - Geographic (GEOR)
- Total Revenues: International
- 13,451.00
- 14,331.00
- 5,632.00
- 17,171.00
- 10,803.00
- Revenue - Geographic (GEOR)
- Net Sales: In-Line Products: Eliquis: U.S.
- 8,592.00
- 7,786.00
- 6,456.00
- 5,485.00
- 4,755.00
- Revenue - Geographic (GEOR)
- Net Sales: In-Line Products: Opdivo: U.S.
- 5,283.00
- 4,812.00
- 4,202.00
- 3,945.00
- 4,344.00
- Revenue - Geographic (GEOR)
- Net Sales: In-Line Products: Pomalyst/Imnovid: U.S.
- 2,357.00
- 2,438.00
- 2,249.00
- 2,136.00
- 226.00
- Revenue - Geographic (GEOR)
- Net Sales: In-Line Products: Orencia: U.S.
- 2,754.00
- 2,638.00
- 2,410.00
- 2,268.00
- 2,146.00
- Revenue - Geographic (GEOR)
- Net Sales: In-Line Products: Sprycel: U.S.
- 1,446.00
- 1,497.00
- 1,297.00
- 1,295.00
- 1,191.00
- Revenue - Geographic (GEOR)
- Net Sales: In-Line Products: Yervoy: U.S.
- 1,388.00
- 1,304.00
- 1,265.00
- 1,124.00
- 1,004.00
- Revenue - Geographic (GEOR)
- Net Sales: New Product Portfolio: Camzyos: U.S.
- 226.00
- 24.00
- 0.00
- --
- --
- Revenue - Geographic (GEOR)
- Net Sales: New Product Portfolio: Camzyos: International
- 5.00
- 0.00
- 0.00
- --
- --
- Revenue - Geographic (GEOR)
- Net Sales: New Product Portfolio: Sotyktu: U.S.
- 157.00
- 8.00
- 0.00
- --
- --
- Revenue - Geographic (GEOR)
- Net Sales: New Product Portfolio: Sotyktu: International
- 13.00
- 0.00
- 0.00
- --
- --
- Revenue - Geographic (GEOR)
- Regional Revenues: Other
- 699.00
- 834.00
- 852.00
- 631.00
- 524.00
- Revenue - Geographic (GEOR)
- Net Sales: In-Line Products: Orencia: International
- 847.00
- 826.00
- 896.00
- 889.00
- 831.00
- Revenue - Geographic (GEOR)
- Net Sales: In-Line Products: Sprycel: International
- 484.00
- 668.00
- 820.00
- 845.00
- 919.00
- Revenue - Geographic (GEOR)
- Net Sales: In-Line Products: Yervoy: International
- 850.00
- 827.00
- 761.00
- 458.00
- 485.00
- Revenue - Geographic (GEOR)
- Net Sales: In-Line Products: Eliquis: International
- 3,614.00
- 4,003.00
- 4,306.00
- 3,683.00
- 3,174.00
- Revenue - Geographic (GEOR)
- Regional Revenues: International
- 12,752.00
- 13,497.00
- 16,319.00
- 5,457.00
- 4,013.00
- Revenue - Geographic (GEOR)
- Net Sales: In-Line Products: Opdivo: International
- 3,726.00
- 3,437.00
- 3,321.00
- 3,047.00
- 2,860.00
- Revenue - Geographic (GEOR)
- Net Sales: Recent LOE Products: Abraxane: U.S.
- 709.00
- 580.00
- 898.00
- 873.00
- 122.00
- Revenue - Geographic (GEOR)
- Net Sales: Recent LOE Products: Abraxane: International
- 295.00
- 231.00
- 283.00
- 374.00
- 44.00
- Revenue - Geographic (GEOR)
- Net Sales: In-Line Products: Pomalyst/Imnovid: International
- 1,084.00
- 1,059.00
- 1,083.00
- 934.00
- 96.00
- Revenue - Geographic (GEOR)
- Net Sales: Recent LOE Products: Revlimid: U.S.
- 5,266.00
- 8,359.00
- 8,695.00
- 8,291.00
- 899.00
- Revenue - Geographic (GEOR)
- Net Sales: Recent LOE Products: Revlimid: International
- 831.00
- 1,619.00
- 4,126.00
- 3,815.00
- 400.00
- Revenue - Geographic (GEOR)
- Net Sales: New Product Portfolio: Reblozyl: U.S.
- 811.00
- 591.00
- 485.00
- 259.00
- 0.00
- Revenue - Geographic (GEOR)
- Net Sales: New Product Portfolio: Reblozyl: International
- 197.00
- 126.00
- 66.00
- 15.00
- 0.00
- Revenue - Geographic (GEOR)
- Net Sales: New Product Portfolio: Zeposia: U.S.
- 324.00
- 177.00
- 99.00
- 10.00
- 0.00
- Revenue - Geographic (GEOR)
- Net Sales: New Product Portfolio: Zeposia: International
- 110.00
- 73.00
- 35.00
- 2.00
- 0.00
- Revenue - Geographic (GEOR)
- Net Sales: New Product Portfolio: Breyanzi: U.S.
- 303.00
- 151.00
- 84.00
- 0.00
- --
- Revenue - Geographic (GEOR)
- Net Sales: New Product Portfolio: Breyanzi: International
- 61.00
- 31.00
- 3.00
- 0.00
- --
- Revenue - Geographic (GEOR)
- Net Sales: New Product Portfolio: Abecma: U.S.
- 358.00
- 297.00
- 158.00
- 0.00
- --
- Revenue - Geographic (GEOR)
- Net Sales: New Product Portfolio: Abecma: International
- 114.00
- 91.00
- 6.00
- 0.00
- --
- Revenue - Geographic (GEOR)
- Net Sales: New Product Portfolio: Opdualag: U.S.
- 617.00
- 252.00
- 0.00
- --
- --
- Revenue - Geographic (GEOR)
- Net Sales: New Product Portfolio: Opdualag: International
- 10.00
- 0.00
- 0.00
- --
- --